You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動 | 開拓藥業-B午後漲超24%,年初至今累漲635%
uSMART盈立智投 04-28 14:23

uSMART盈立智投4月28日消息,週三港股,開拓藥業-B繼續逆天漲勢,截至14:21,開拓藥業-B漲24.15%,報77.1港元,股價續創新高。

值得注意的是,股價已經連漲三天,累計漲幅高達56.19%;年初至今,累計漲幅高達635%,位居港股今年漲幅榜第五。

開拓藥業於4月25日公佈,在美國進行的用於治療輕中症男性新型肺炎患者的普克魯胺III期臨牀試驗已完成首位患者入組和給藥。公司指將加快臨牀試驗,並與美國FDA保持密切溝通。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account